WIRE — Doctors say patients should not stop medical treatment that used the medicines to treat high blood pressure, fungal infections, and organ transplant rejection; WHOâ s International Agency for Research on Cancer has placed hydrochlorothiazide, voriconazole and tacrolimus in Group 1 of the IARC Monographs
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.